Medical Devices US

US Allergy Diagnostics Market Analysis, 2024–2034

US Allergy Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Allergen, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.77 Bn Estimated value
Estimate 2025 $2.93 Bn 45.6% of the global market
Projected 2034 $4.78 Bn 63.3% Adds $1.85 Bn over 9 forecast years
CAGR 2025–2034 5.6% Faster than 39% of 173 Medical Devices markets here
Key players 5
  • US is 45.61% of the global market.
  • In North America, the largest is US (this report) at $2.93 Bn.
  • Fastest growing: Canada at 8.3% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.85 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Allergy Diagnostics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.77 Bn — —
2025 (base) $2.93 Bn +$155.2 Mn —
2026 (forecast) $3.09 Bn +$163.9 Mn +5.6%
2027 (forecast) $3.26 Bn +$173.0 Mn +11.5%
2028 (forecast) $3.45 Bn +$182.7 Mn +17.8%
2029 (forecast) $3.64 Bn +$193.0 Mn +24.4%
2030 (forecast) $3.84 Bn +$203.8 Mn +31.3%
2031 (forecast) $4.06 Bn +$215.2 Mn +38.7%
2032 (forecast) $4.28 Bn +$227.2 Mn +46.4%
2033 (forecast) $4.52 Bn +$239.9 Mn +54.6%
2034 (forecast) $4.78 Bn +$253.4 Mn +63.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $6.42 Bn
  2. US (this report) $2.93 Bn
  3. North America $2.79 Bn
  4. Europe $1.29 Bn
  5. APAC $1.27 Bn
  6. China $584.9 Mn
  7. Canada $477.5 Mn
  8. Japan $356.4 Mn
  9. Latin America $304.9 Mn
  10. Middle East $286.2 Mn
  11. Germany $255.0 Mn
  12. France $190.0 Mn
  13. Italy $157.1 Mn
  14. UK $150.7 Mn
  15. Brazil $154.5 Mn
  16. Spain $123.0 Mn
  17. Ecuador $125.4 Mn
  18. Saudi Arabia $115.3 Mn
  19. India $114.1 Mn
  20. Africa $108.4 Mn
  21. Mexico $91.0 Mn
  22. Australia $77.0 Mn
  23. Russia $61.1 Mn
  24. New Zealand $60.4 Mn
  25. South Africa $47.2 Mn
  26. UAE $33.0 Mn
  27. Egypt $19.7 Mn
  28. Philippines $15.8 Mn
  29. Malaysia $9.8 Mn
  30. Hong Kong $9.5 Mn
  31. Singapore $7.2 Mn
  32. Thailand $7.2 Mn
  33. Kenya $4.3 Mn

The US Allergy Diagnostics Market Analysis Executive Summary

Allergy diagnostics find what a person is allergic to, using skin prick tests and blood tests for IgE antibodies.

Key segments of the allergy Diagnostics market include test (In Vitro IgE Tests, Skin Prick Tests and Component Testing) and allergen (Food, Inhaled and Drug).

US Allergy Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the allergy Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the allergy Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the allergy Diagnostics market.

Competitive Landscape for Allergy Diagnostics Market in US

The allergy Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Allergy Diagnostics Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how allergy Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Allergy Diagnostics right now, from free public sources.

Latest research 126 papers since 2021 (worldwide)

  1. Editorial: Advances in molecular diagnostics of allergy: novel allergens, biomarkers, and technical developments. Frontiers in immunology, 2026
  2. Relative IgE predominance within a core nsLTP panel may support clinical interpretation of multiplex sensitization profiles. European annals of allergy and clinical immunology, 2026
  3. Parasites and allergies: a complex bidirectional relationship from evolutionary origins to modern therapeutics. Antonie van Leeuwenhoek, 2026
  4. Editorial: Innovations in allergy diagnostics and management: a global perspective. Frontiers in allergy, 2026
  5. The Basophil Activation Test in Allergy Diagnostics: Clinical Applications, Methodological Challenges, and Proposed Clinical Frameworks. Cells, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Allergy Diagnostics in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How much research is published on Allergy Diagnostics?
PubMed lists 126 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Allergy Diagnostics in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in US

See all
Same topic, other categories

Related on allergies and diagnostics and lab testing

See the topic